SCHEMBL21757372

SCHEMBL21757372

Cc1cc(F)c(C)c(OCCCC(C)(C)C(=O)OCC(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 5/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP2C8 P10632 2/20 0.43
TSHR P16473 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
TTR P02766 1/20 0.43
CYP1A2 P05177 1/20 0.43
CHRM1 P11229 1/20 0.43
CYP2C9 P11712 1/20 0.43
ADRA1A P35348 1/20 0.43
PPARG P37231 1/20 0.43
HTR2B P41595 1/20 0.43
SLCO1B3 Q9NPD5 1/20 0.43
CISD1 Q9NZ45 1/20 0.43
SLCO1B1 Q9Y6L6 1/20 0.43
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 1/20 0.38
HTT P42858 1/20 0.37
NR1H4 Q96RI1 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21757422 0.86 PPARA (0.43) PPARASMN1; SMN2CYP2C8TSHRTDP1
SCHEMBL21757404 0.82 PPARA (0.43) PPARASMN1; SMN2CYP2C8TSHRTDP1
SCHEMBL21753583 0.81 PPARA (0.63) PPARASMN1; SMN2CYP2C8TSHRTDP1
SCHEMBL29840626 0.81 PPARA (0.63) PPARASMN1; SMN2CYP2C8TSHRTDP1
SCHEMBL21757389 0.79 PPARA (0.40) PPARASMN1; SMN2CYP2C8TSHRTDP1
SCHEMBL21757391 0.77 PPARA (0.39) PPARASMN1; SMN2CYP2C8TSHRTDP1
SCHEMBL21753566 0.75 PPARA (0.43) PPARASMN1; SMN2CYP2C8TSHRTDP1
SCHEMBL21757415 0.75 PPARA (0.43) PPARASMN1; SMN2CYP2C8TSHRTDP1
SCHEMBL24304061 0.73 PPARA (0.39) PPARASMN1; SMN2CYP2C8TSHRTDP1
SCHEMBL21757377 0.72 LTB4R (0.38) PPARASMN1; SMN2CYP2C8TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119333-A1 PHENOXY ACID COMPOUNDS AND MEDICAL USES THEREOF QINGDAO WHOLESOMTECH CO., LTD. (CN) 2022-04-21 US disclosed
EP-3842410-A1 FIBRIC ACID COMPOUND AND MEDICAL USE THEREOF Beijing Wholesomeyird Sci & Tech Co., Ltd. (CN) 2021-06-30 EP disclosed
WO-2020038464-A1 FIBRIC ACID COMPOUND AND MEDICAL USE THEREOF 北京厚燊药德科技有限责任公司 2020-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119333-A1 PHENOXY ACID COMPOUNDS AND MEDICAL USES THEREOF PYGL, SLC10A1, GYS2 PPARA 10/4885SMN1; SMN2 3774/4885CYP2C8 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.